ATYR: aTyr Pharma, Inc. Stock

by  •  • Comments Off on ATYR: aTyr Pharma, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 296.79
Enterprise Value ($M) 286.24
Book Value ($M) 74.86
Book Value / Share 0.84
Price / Book 3.96
NCAV ($M) 60.89
NCAV / Share 0.69
Price / NCAV 4.87

Profitability (mra)
Return on Invested Capital (ROIC) -0.72
Return on Assets (ROA) -0.56
Return on Equity (ROE) -0.75

Liquidity (mrq)
Quick Ratio 7.79
Current Ratio 7.79

Balance Sheet (mrq) ($M)
Current Assets 83.27
Assets 97.25
Liabilities 22.38
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.23
Operating Income -67.91
Net Income -64.02
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -69.12
Cash from Investing 17.23
Cash from Financing 39.86

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-08 13G/A Federated Hermes, Inc. 17.47 0.00
11-14 13G/A Logos Global Management LP 2.10 -69.83
10-15 13G Point72 Asset Management, L.P. 6.20

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPO
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-08 242,043 1,074,167 22.53
2025-05-07 325,320 1,012,188 32.14
2025-05-06 335,531 1,154,308 29.07
2025-05-05 241,804 701,411 34.47

(click for more detail)

Similar Companies
ATHA – Athira Pharma, Inc. ATNF – 180 Life Sciences Corp.
ATOS – Atossa Therapeutics, Inc. AVTX – Avalo Therapeutics, Inc.
AYTU – Aytu BioPharma, Inc.


Financial data and stock pages provided by
Fintel.io